company background image
MOVE logo

Medacta Group Informe acción SWX:MOVE

Último precio

CHF118.80

Capitalización de mercado

CHF2.4b

7D

2.4%

1Y

1.9%

Actualizada

15 May, 2024

Datos

Finanzas de la empresa +

Medacta Group SA

Informe acción SWX:MOVE

Capitalización de mercado: CHF2.4b

Resumen de acción MOVE

Medacta Group SA desarrolla, fabrica y distribuye dispositivos médicos ortopédicos y neuroquirúrgicos Europa, Norteamérica, Asia-Pacífico y a escala internacional.

Acerca de la empresa

MOVE fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Recompensas

Cotiza un 25.8% por debajo de nuestra estimación de su valor justo
Se prevé un crecimiento anual de los beneficios de 21.8%
Los beneficios aumentaron un 2.4% el pasado año
Los analistas coinciden en que el precio de las acciones subirá un 28.3%

Análisis de riesgos

Tiene un alto nivel de endeudamiento

Competidores de Medacta Group SA

Metall Zug

SWX:METN

CHF612.0m

Sonova Holding

SWX:SOON

CHF17.0b

Straumann Holding

SWX:STMN

CHF19.1b

Ypsomed Holding

SWX:YPSN

CHF4.5b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Medacta Group
Historical stock prices
Current Share PriceCHF118.80
52 Week HighCHF135.00
52 Week LowCHF98.10
Beta1.17
1 Month Change2.24%
3 Month Change-9.59%
1 Year Change1.89%
3 Year Change-0.17%
5 Year Change46.67%
Change since IPO23.62%

Noticias y actualizaciones recientes

We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

May 01
We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Apr 17
Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Mar 29
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Feb 22
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Recent updates

We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

May 01
We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Apr 17
Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Mar 29
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Feb 22
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Feb 07
Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Dec 18
Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Dec 04
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Nov 15
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

Oct 30
Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Oct 17
If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Sep 29
Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Aug 11
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Jul 27
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

Jul 03
Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Apr 28
At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Is Medacta Group (VTX:MOVE) A Risky Investment?

Apr 08
Is Medacta Group (VTX:MOVE) A Risky Investment?

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Dec 25
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Dec 09
Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Nov 09
Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

Sep 16
Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Aug 20
The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Jul 02
Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

May 28
Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

May 12
Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Mar 31
These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Mar 17
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Feb 07
Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Dec 10
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Nov 05
Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Sep 30
Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Aug 26
Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Jul 20
Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

May 19
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

Apr 05
We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition

Mar 02
What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition

Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?

Feb 02
Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?

The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More

Jan 12
The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More

Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture

Dec 21
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture

Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?

Dec 03
Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?

Rentabilidad de los accionistas

MOVECH Medical EquipmentMercado CH
7D2.4%5.9%2.1%
1Y1.9%5.4%-0.2%

Rentabilidad vs. Industria: Los resultados de MOVE fueron inferiores a los de la industria Swiss Medical Equipment, que obtuvo un rendimiento del 5.4% el año pasado.

Rentabilidad vs. Mercado: MOVE superó al mercado Swiss, que obtuvo un rendimiento del -0.9% el año pasado.

Volatilidad de los precios

Is MOVE's price volatile compared to industry and market?
MOVE volatility
MOVE Average Weekly Movement2.8%
Medical Equipment Industry Average Movement4.0%
Market Average Movement3.6%
10% most volatile stocks in CH Market7.7%
10% least volatile stocks in CH Market1.8%

Precio estable de las acciones: MOVE no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de MOVE (3%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19581,696Francesco Siccardiwww.medacta.com

Medacta Group SA desarrolla, fabrica y distribuye dispositivos médicos ortopédicos y neuroquirúrgicos en Europa, Norteamérica, Asia-Pacífico e internacionalmente. Ofrece herramientas personalizadas de planificación en 3D para su uso en procedimientos de cadera, rodilla, hombro, sustitución articular, medicina deportiva y columna vertebral. Medacta Group SA se fundó en 1958 y tiene su sede en Castel San Pietro, Suiza.

Resumen de fundamentos de Medacta Group SA

¿Cómo se comparan los beneficios e ingresos de Medacta Group con su capitalización de mercado?
Estadísticas fundamentales de MOVE
Capitalización bursátilCHF2.37b
Beneficios(TTM)CHF46.43m
Ingresos (TTM)CHF500.70m

51.0x

Ratio precio-beneficio (PE)

4.7x

Ratio precio-ventas (PS)

¿Está MOVE sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de MOVE
Ingresos€510.78m
Coste de los ingresos€162.93m
Beneficio bruto€347.85m
Otros gastos€300.49m
Beneficios€47.36m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

Jul 24, 2024

Beneficios por acción (BPA)2.38
Margen bruto68.10%
Margen de beneficio neto9.27%
Ratio deuda/patrimonio49.4%

¿Cómo se ha desempeñado MOVE a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

0.5%

Rentabilidad actual por dividendo

25%

Ratio de pagos